Alterations in the relative abundance of Faecalibacterium prausnitzii correlate with changes in fecal calprotectin in patients with ileal Crohn's disease: a longitudinal study

被引:16
|
作者
Bjorkqvist, Olle [1 ]
Repsilber, Dirk [1 ]
Seifert, Maike [2 ]
Brislawn, Colin [3 ]
Jansson, Janet [3 ]
Engstrand, Lars [2 ]
Rangel, Ignacio [1 ]
Halfvarson, Jonas [4 ]
机构
[1] Orebro Univ, Sch Med Sci, Orebro, Sweden
[2] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden
[3] Pacific Northwest Natl Lab, Earth & Biol Sci Directorate, Richland, WA 99352 USA
[4] Orebro Univ, Dept Gastroenterol, Fac Med & Hlth, SE-70182 Orebro, Sweden
关键词
Faecalibacterium prausnitzii; Crohn's disease; calprotectin; butyrate; dysbiosis; BUTYRATE-PRODUCING BACTERIA; ULCERATIVE-COLITIS; MICROBIAL ECOLOGY; QUANTITATIVE PCR; PATHOGENESIS; INFLAMMATION; METABOLISM; TWIN;
D O I
10.1080/00365521.2019.1599417
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Objectives: Crohn's disease is characterized by a gut dysbiosis with decreased abundance of butyrate producers such as Faecalibacterium prausnitzii. Although F. prausnitzii secretes anti-inflammatory molecules, few studies have addressed the importance of F. prausnitzii in a longitudinal setting. We aimed to examine the relationship between temporal profiles of F. prausnitzii, the C. leptum group, overall butyrate production, and inflammatory activity. Material and methods: Fecal samples (n = 59) were collected every third month from nine patients with ileal Crohn's disease. The abundance of F. prausnitzii and C. leptum was quantified relative to the total amount of bacteria using quantitative-PCR. To assess butyrate production of gut microbiota, gene copy numbers of the butyryl-CoA:acetate-CoA transferase (BCoAT) gene were quantified by qPCR. The inflammatory activity was defined by fecal (f)-calprotectin. Results: No correlation between the relative abundance of F. prausnitzii, the C. leptum group, or copy numbers of the BCoAT gene, and f-calprotectin was observed in the total sample set. By analyzing alterations between consecutive samples, a negative correlation between changes in the relative abundance of F. prausnitzii and f-calprotectin was observed (R = -0.39; p = .009). Changes in C. leptum (R = -0.18, p = .23) and number of copies of the BCoAT gene (R = -0.12; p = .42) did not correlate with f-calprotectin. Conclusions: There was an inverse correlation between temporal changes in the relative abundance of F. prausnitzii, but not overall butyrate producing capacity, and changes in inflammatory activity in ileal Crohn's disease. These findings indicate that F. prausnitzii may play a role in gut homeostasis, even though causality is still to be demonstrated.
引用
收藏
页码:577 / 585
页数:9
相关论文
共 50 条
  • [21] Levels of Fecal Calprotectin and the Severity of Postoperative Patients With Crohn's Disease Response
    Boschetti, Gilles
    Drai, Jocelyne
    Flourie, Bernard
    Nancey, Stephane
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 (08): : 1242 - 1242
  • [22] Association between disease duration and usefulness of fecal calprotectin measurement in patients with Crohn's disease
    Eder, Piotr
    Stawczyk-Eder, Kamila
    Lykowska-Szuber, Liliana
    Krela-Kazmierczak, Iwona
    Klimczak, Katarzyna
    Szymczak, Aleksandra
    Szachta, Patrycja
    Linke, Krzysztof
    POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ-POLISH ARCHIVES OF INTERNAL MEDICINE, 2014, 124 (1-2): : 51 - 57
  • [23] Consecutive fecal calprotectin measurements for predicting relapse in pediatric Crohn's disease patients
    Foster, Alice Jane
    Smyth, Matthew
    Lakhani, Alam
    Jung, Benjamin
    Brant, Rollin F.
    Jacobson, Kevan
    WORLD JOURNAL OF GASTROENTEROLOGY, 2019, 25 (10) : 1266 - 1277
  • [24] Does fecal calprotectin predict relapse in patients with Crohn's disease and ulcerative colitis?
    Garcia-Sanchez, Valle
    Iglesias-Flores, Eva
    Gonzalez, Raul
    Gisbert, Javier P.
    Maria Gallardo-Valverde, Jose
    Gonzalez-Galilea, Angel
    Naranjo-Rodriguez, Antonio
    de Dios-Vega, Juan F.
    Muntane, Jordi
    Gomez-Camacho, Federico
    JOURNAL OF CROHNS & COLITIS, 2010, 4 (02): : 144 - 152
  • [25] Consecutive fecal calprotectin measurements for predicting relapse in pediatric Crohn's disease patients
    Alice Jane Foster
    Matthew Smyth
    Alam Lakhani
    Benjamin Jung
    Rollin F Brant
    Kevan Jacobson
    World Journal of Gastroenterology, 2019, 25 (10) : 1266 - 1277
  • [26] Changes of fecal calprotectin concentrations after adalimumab induction therapy in patients with moderate-to-severe Crohn's disease
    Lee, K. -M.
    Yang, S. -K.
    Kim, H. J.
    Kim, Y. H.
    Song, G. A.
    Im, J. P.
    Jang, B. I.
    Jung, S. -A.
    Jeen, Y. T.
    Koo, J. S.
    Cheon, J. H.
    Park, S. J.
    Kim, Y. J.
    Eun, C. S.
    Kim, T. -O.
    JOURNAL OF CROHNS & COLITIS, 2015, 9 : S362 - S362
  • [27] INFLIXIMAB CAN BE DISCONTINUED FOR THE CROHN'S DISEASE PATIENTS WITH STRICT MONITORING OF FECAL CALPROTECTIN; PROSPECTIVE CONTROLLED STUDY
    Toyokawa, Tatsuya
    Fujita, Isao
    Horii, Joichiro
    GASTROINTESTINAL ENDOSCOPY, 2018, 87 (06) : AB371 - AB371
  • [28] ELEVATED FECAL CALPROTECTIN IN HEALTHY FIRST DEGREE RELATIVES OF PATIENTS WITH CROHN'S DISEASE IS ASSOCIATED WITH FUTURE DIAGNOSIS OF CROHN'S DISEASE
    Lee, Sun-Ho
    Power, Namita
    Turpin, Williams
    Bedrani, Larbi
    Garay, Juan Antonio Raygoza
    Smith, Michelle I.
    Madsen, Karen
    Turner, Dan
    Marshall, John K.
    Seidman, Ernest G.
    Bernstein, Charles N.
    Feagan, Brian G.
    Moayyedi, Paul
    Steinhart, A. Hillary
    Silverberg, Mark S.
    Griffiths, Anne M.
    Espin-Garcia, Osvaldo
    Xu, Wei
    Paterson, Andrew
    Croitoru, Kenneth
    GASTROENTEROLOGY, 2019, 156 (06) : S413 - S413
  • [29] Capsule endoscopic findings correlate with fecal calprotectin and C-reactive protein in patients with suspected small-bowel Crohn's disease
    Hoog, Charlotte M.
    Bark, Lars-Ake
    Brostrom, Olle
    Sjoqvist, Urban
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2014, 49 (09) : 1084 - 1090
  • [30] Fecal calprotectin diagnostic level gradient along the small bowel in patients with Crohn's disease
    Ukashi, O.
    Kopylov, U.
    Ungar, B.
    Talan Asher, A.
    Shachar, E.
    Engel, T.
    Albshesh, A.
    Yablecovitch, D.
    Lahat, A.
    Eliakim, R.
    Ben-Horin, S.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i1052 - i1052